• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Lipitor (atorvastatin) Recall Press Release Jun 2003


This is the text of a letter from Albers Medical Distributors, Inc. Contact the company for a copy of any referenced enclosures.



June 9, 2003


On May 22, you were advised that certain lots of Lipitor 10 mg, NDC 0071- 0155-23, which were repackaged by Med-Pro, Inc. of Lexington, NE were being voluntarily recalled.

In conjunction with the Food and Drug Administration, we are expanding our original voluntary recall to include all lots of Lipitor that Albers purchased, which were packaged by Med-Pro. Although the FDA has not tested all of the additional lots, Albers is voluntarily recalling them as a precautionary measure. All lots subject to this recall are on the attached list (PDF format)

The same procedures outlined to you on May 22, 2003 apply. You should immediately cease distribution or use of these products. This recall goes to the consumer level.

If you have distributed or sold any of these products to other distributors, retail pharmacies, or individual persons you should provide notice to them of this recall and advise them that the recall information should be provided to all consumers who received these products. These products should not be used. They should be returned immediately.

Products should be shipped to:

Albers Medical Distributors, Inc
4400 Broadway, Suite 116
Kansas City, MO 64111